资讯

FDA Approves Losartan Oral Suspension Arbli Furoscix (furosemid injection) Loop diuretic Treatment of edema in patients with chronic kidney disease, including nephrotic syndrome. Wearable Furosemide ...
As of Wednesday, April 09, scPharmaceuticals Inc.’s SCPH share price has dipped by 9.30%, which has investors questioning if ...
FDA Approves Losartan Oral Suspension Arbli Furoscix (furosemid injection) Loop diuretic Treatment of edema in patients with chronic kidney disease, including nephrotic syndrome. Wearable ...
Its lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion due to fluid overload in adults with ...
Its lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion due to fluid overload in adults with ...